< Back

PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025

Dec 10, 2025 at 11:30 AM EST

PETACH TIKVA, Israel, Nov. 25, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will participate in a virtual Key Opinion Leader (KOL) event hosted by ROTH Capital Partners.
 

KOL Event Information:
 

Webinar Title: The Science and Business Case for D-PLEX100 (Tackling Surgical Site Infections)
Date: Wednesday, December 10, 2025
Time: 11:30 AM Eastern Time
Registration link: https://roth.zoom.us/webinar/register/WN_yP7JWS3xSrqCaDQTwGazyA#/registration